Evolus Reports Third Quarter 2021 Results and Provides Business Update

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

United States ,America ,Davidk Erickson ,David Moatazedi ,Exchange Commission On ,Drug Administration ,Evolus Inc ,Strength Phase Ii Clinical Program ,Nasdaq ,Exchange Commission ,Daewoong Pharmaceutical Co Ltd ,Record Quarter ,Revenue Grew ,Cash Position ,Demonstrate Extended ,Chief Executive ,Recent Corporate ,Evolus Founders ,Investor Relations ,Private Securities Litigation Reform Act ,Medytox Settlement Agreements ,Quarterly Report ,Gross Profit Margin ,Adjusted Gross Profit ,Evolus Rewards ,Botulinum Toxin Type ,Glabellar Frown Lines ,What Impact ,Higher Doses ,Clarivate Aesthetic Injectables Market Insights ,Media Contact ,Comprehensive Loss ,Balance Sheet Data ,Sheet Data ,Adjusted Gross Profit Margin ,Technology ,Business ,Health ,Globe Newswire ,